Dr Reddy's inks $370 million licensing deal to sell Immutep's cancer drug Eftilagimod Alfa
Dr Reddy’s will pay Immutep US$ 20 million upfront and could deliver as much as US$ 349.5 million in regulatory and commercial milestones
Dr Reddy’s will pay Immutep US$ 20 million upfront and could deliver as much as US$ 349.5 million in regulatory and commercial milestones
The project focuses on recovering high-quality polycarbonate, a valuable polymer material used in the construction of the filters
Freenome expects the combined company to receive approximately $330 million in proceeds at closing
Alport Syndrome is caused by genetic mutations affecting type IV collagen in the kidneys, ears, and eyes
NAEH can cause heavy or abnormal bleeding and, if left untreated, may progress to uterine cancer
MRI is particularly valuable in pediatric care due to its non-invasive nature
This campaign is to raise awareness about the crucial role helmet usage plays in saving lives
Implementing PFAS testing in the early development stages allows medical device manufacturers to prepare for potential regulatory updates
Suffering from acute migraine? You may soon bid adieu to the debilitating headache
Subscribe To Our Newsletter & Stay Updated